Fact and fiction in tuberculosis vaccine research: 10 years later.
about
Mycobacterium tuberculosis: success through dormancyRecent advances towards tuberculosis control: vaccines and biomarkersTuberculosis: From an incurable scourge to a curable disease - journey over a millenniumIdentification of novel Mycobacterium tuberculosis CD4 T-cell antigens via high throughput proteome screening.Opportunities for Improved Serodiagnosis of Human Tuberculosis, Bovine Tuberculosis, and ParatuberculosisStructural analysis of Mycobacterium tuberculosis ATP-binding cassette transporter subunit UgpB reveals specificity for glycerophosphocholineSafety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trialBreast lumps: a rare site for rheumatoid nodules.Novel vaccination strategies against tuberculosis.Host cell-induced components of the sulfate assimilation pathway are major protective antigens of Mycobacterium tuberculosis.Toward Understanding the Essence of Post-Translational Modifications for the Mycobacterium tuberculosis ImmunoproteomeIdentification of probable early-onset biomarkers for tuberculosis disease progression.Tuberculosis vaccine: time to look into future.Central memory CD4+ T cells are responsible for the recombinant Bacillus Calmette-Guérin ΔureC::hly vaccine's superior protection against tuberculosisThe tuberculosis vaccine candidate Bacillus Calmette-Guérin ΔureC::hly coexpressing human interleukin-7 or -18 enhances antigen-specific T cell responses in miceA novel tuberculosis antigen identified from human tuberculosis granulomasTransgenic carrot expressing fusion protein comprising M. tuberculosis antigens induces immune response in miceInnate responses induced by whole inactivated virus or subunit influenza vaccines in cultured dendritic cells correlate with immune responses in vivo.Recent developments in the epidemiology and management of tuberculosis - new solutions to old problems?Viewpoint: Challenges and opportunities in tuberculosis research.The tuberculous granuloma: an unsuccessful host defence mechanism providing a safety shelter for the bacteria?Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection.Current status of new tuberculosis vaccine in children.Antibody-mediated immunity against tuberculosis: implications for vaccine developmentRecombinant vaccines and the development of new vaccine strategies.Mycobacterial L-forms are found in cord blood: A potential vertical transmission of BCG from vaccinated mothers.Adenovirally-Induced Polyfunctional T Cells Do Not Necessarily Recognize the Infected Target: Lessons from a Phase I Trial of the AERAS-402 Vaccine.Integrative immunoinformatics for Mycobacterial diseases in R platform.Role of bacillus Calmette-Guérin in the treatment of advanced melanoma.IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions.Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology.Tuberculous meningitis in adults: a review of a decade of developments focusing on prognostic factors for outcome.The dual role of biomarkers for understanding basic principles and devising novel intervention strategies in tuberculosis.Infections Caused by Mycobacterium tuberculosis in Recipients of Hematopoietic Stem Cell Transplantation.Mycobacterium tuberculosis virulence: insights and impact on vaccine development.Immunogenicity and Protective Efficacy of a Fusion Protein Tuberculosis Vaccine Combining Five Esx Family Proteins.Design and Construction of a Cloning Vector Containing the hspX Gene of Mycobacterium tuberculosis.Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice.Controversies and unresolved issues in tuberculosis prevention and control: a low-burden-country perspective.Back to the future: host-targeted chemotherapeutics for drug-resistant TB.
P2860
Q26852023-070FF56A-43F3-437C-B806-E5D948719E08Q26859739-FA83EAD4-2232-4DA5-980C-2AF8E1DE389AQ26865560-6D73183C-3BAE-4C81-8A3D-71F6E41FFF1BQ27303136-01FCC376-4E5C-455B-9152-73F1C32A5FA2Q27495985-CA581CC0-15DC-46E5-9ABB-5E63203B8536Q27687788-6540C525-DD10-4C80-AEB9-644AB76D5FB0Q29620144-EFAABEEC-FDAF-4BAD-BA75-4ECD414DD9DAQ30358219-5F3FFF01-F48C-492D-8D4F-BD7801EA9E47Q30363188-B546BB44-876E-4E88-9C6A-18C57D59B7A6Q30580895-6E533B4F-F9D5-44E9-B56B-C05B00C01D4FQ34024201-F937D185-5601-4292-B8BD-2881A61B8E3CQ34038097-6C0FB594-86DE-492B-9B93-9607273F74C3Q34290767-AF769451-21B8-4320-9000-8272AE06A623Q34563543-6B971CC4-8489-4FEB-9416-81851D9620BFQ35043659-40E82494-7D22-411A-A765-2D1D8DFEBDC7Q35325530-14024230-F1D3-41FB-AB4A-EB1DFFB9E6CFQ35530615-571B66DE-17F5-43E5-A25F-4C427C7F011AQ35560781-7EE119EA-78E5-43A8-AEA2-24C807917E35Q35715390-26DC9143-1BEF-4BA2-97C4-575F68136FB9Q35907389-BB394A9F-F86D-4A09-B445-C9FA88A8EAD4Q36090400-37617F39-3058-43AB-87D6-44B2E9914A09Q37071295-3FBBA4C5-AE85-4D11-AD5A-B85EB6359BFBQ37130796-27823F36-EDBC-4779-AA2F-166F01A4CB02Q37137882-8F7A47ED-214E-4D20-A865-19FBBFC47038Q37370940-5F60FB32-326B-4E43-A861-956BEDD631C5Q37375946-04AEB1D3-C540-4D75-8616-16CF92D906BBQ37479096-FC01D3AF-4B28-40E6-B22B-53ABF77A6D53Q37601159-7CB846DE-93D8-4E33-8D29-86248D481560Q37952235-0E63AC44-9E1B-486D-A26E-4C0BEF0DBDA8Q37988577-24DE926B-967B-49F3-99C2-B59A3DE30FA7Q38031924-9E483C92-578F-459A-958A-85A590107D4BQ38041192-9B576147-5A84-4674-A92D-093DAD2CF241Q38062582-15CA35BA-3D95-454F-A60A-FCAF24D62D85Q38248018-57B663F4-39E4-4824-834B-716480D57FADQ38539493-B4C6BDB6-6E42-4E98-A7E2-EC110DC1CF80Q38670391-E8AA8C8E-F48A-485E-B1D5-DF9B3E625B56Q38772529-3669B01A-656B-4FA3-9CA6-A7FADEFBE414Q39202380-8A187118-058F-488F-AC70-0390B639D7DCQ39636742-092400F0-862E-4FE9-8FE9-5A47B8B853F4Q39637771-87B00498-AE84-48C4-862F-35835B166547
P2860
Fact and fiction in tuberculosis vaccine research: 10 years later.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Fact and fiction in tuberculosis vaccine research: 10 years later.
@en
Fact and fiction in tuberculosis vaccine research: 10 years later.
@nl
type
label
Fact and fiction in tuberculosis vaccine research: 10 years later.
@en
Fact and fiction in tuberculosis vaccine research: 10 years later.
@nl
prefLabel
Fact and fiction in tuberculosis vaccine research: 10 years later.
@en
Fact and fiction in tuberculosis vaccine research: 10 years later.
@nl
P1476
Fact and fiction in tuberculosis vaccine research: 10 years later.
@en
P304
P356
10.1016/S1473-3099(11)70146-3
P577
2011-08-01T00:00:00Z